Search News
| 44.06 Delayed Data As of Sep 21 |  +0.31 / +0.71%Today’s Change | 33.20 Today|||52-Week Range 44.20 | +21.65% Year-to-Date |
| Previous close | 43.75 |
| Today’s open | 43.78 |
| Day’s range | 43.61 - 44.20 |
| Volume | 35,192,233 |
| Average volume (3 months) | 19,944,287 |
| Market cap | $258.3B |
| Earnings growth (last year) | +200.58% |
| Earnings growth (this year) | +12.80% |
| Earnings growth (next 5 years) | +7.25% |
| Revenue growth (last year) | -0.53% |
| P/E ratio | 11.8 |
| Price/Sales | 4.18 |
| Price/Book | 3.70 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.51 | -0.59% |
| MRKMerck | +0.32 | +0.45% |
| ABBVAbbVie | -0.42 | -0.45% |
| JNJJohnson & Johnson | +0.90 | +0.63% |
| Next reporting date | October 30, 2018 |
| EPS forecast (this quarter) | $0.74 |
| Annual revenue (last year) | $52.5B |
| Annual profit (last year) | $21.3B |
| Net profit margin | 40.55% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
Chief Operating Officer & Director Albert Bourla |
Corporate headquarters New York, New York |
